Evidence map›Paper›PMID 42460841›Full record

ArticleJournal of comparative effectiveness research2026

Lung cancer screening in Lithuania: a cost-effectiveness analysis.

Hilde Ten Berge, Greta Piazza, Dianne Ramaker, Xuanqi Pan, Titas Bukšnys, Saulius Cicėnas, Skaidrius Miliauskas, Giedre Smailyte, Rolandas Zablockis, Marius Zemaitis and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of comparative effectiveness research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hilde Ten BergeInstitute for Diagnostic Accuracy, Groningen, The Netherlands.
Greta PiazzaInstitute for Diagnostic Accuracy, Groningen, The Netherlands.
Dianne RamakerInstitute for Diagnostic Accuracy, Groningen, The Netherlands.
Xuanqi PanInstitute for Diagnostic Accuracy, Groningen, The Netherlands.
Titas BukšnysMarket Access Department, AstraZeneca, Vilnius, Lithuania.
Saulius CicėnasDepartment of Thoracic Surgery & Oncology, National Cancer Institute, Vilnius, Lithuania.
Skaidrius MiliauskasDepartment of Pulmonology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Giedre SmailyteNational Cancer Institute, Laboratory of Cancer Epidemiology, Vilnius, Lithuania.
Rolandas ZablockisClinic of Chest Diseases, Immunology, & Allergology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
Marius ZemaitisDepartment of Pulmonology, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Edvardas DanilaClinic of Chest Diseases, Immunology, & Allergology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Early Detection of CancerLung NeoplasmsMass ScreeningTomography, X-Ray ComputedAgedCost-Benefit AnalysisCost-Effectiveness AnalysisFemaleHumansLithuaniaMaleMarkov ChainsMiddle AgedQuality-Adjusted Life Yearscomputed tomographycost-effectivenessearly detectionlung cancer screeningMarkov model

Identifiers

PMID42460841
PMCPMC13435896

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.